Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C20orf194 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | SEPT11 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | C9orf142 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | C1GALT1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | CD59 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | POPDC3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | SFTA3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | MTCH2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | AC131097.4 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | XKR3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |